Add BrightSurf on Google Email

Mass General Brigham


Study finds improvement in knee pain with exercise and physical therapy

A new study led by Mass General Brigham researchers found that a home exercise program combined with standard or sham physical therapy improved knee pain for participants with osteoarthritis and meniscal tears. The addition of regular visits with a physical therapist resulted in slightly greater pain relief, suggesting the importance o...

SourceMass General Brigham·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateOct 29, 2025

Ingestible pill developed to diagnose intestinal disorder

Researchers developed an ingestible capsule inspired by firefly bioluminescence to diagnose acute mesenteric ischemia, a potentially deadly but often underdiagnosed condition. The capsule generates light after activation by the small intestine's pH, which is transmitted wirelessly to diagnose the condition with 90% accuracy.

SourceMass General Brigham·JournalScience Robotics·DateOct 22, 2025

Daily step counts of 4,000 or more tied to reduced risk of heart disease, mortality in older women

A new study by Mass General Brigham researchers found that daily step counts of 4,000 or more are associated with a 26% lower mortality risk and 27% lower cardiovascular disease risk in older women. The study suggests that even sporadic high-intensity exercise can have significant health benefits.

SourceMass General Brigham·JournalBritish Journal of Sports Medicine·TypeObservational study·DateOct 21, 2025

Large language models prioritize helpfulness over accuracy in medical contexts

Researchers used five advanced LLMs to assess their logical reasoning capabilities and found that they consistently complied with requests for false medical information. Targeted training and fine-tuning improved LLMs' abilities to respond to illogical prompts accurately, but challenges remain in aligning models to every type of user.

SourceMass General Brigham·Journalnpj Digital Medicine·TypeComputational simulation/modeling·DateOct 17, 2025

Study indicates dramatic increase in percentage of US adults who meet new definition of obesity

A study by Mass General Brigham researchers found that the new definition of obesity, which includes measures of body fat distribution, increases the prevalence to 70% among US adults. Those with 'anthropometric-only obesity' have a higher risk of adverse health outcomes, including diabetes and cardiovascular disease.

SourceMass General Brigham·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateOct 15, 2025

Repeated brain tumor sampling uncovers treatment response in patients with glioblastoma

A multi-institutional study found that serially testing tumor samples can detect immune system activation in recurrent glioblastoma even when traditional imaging measures cannot. The researchers used multi-omic analysis and integrated data from various sources to show positive changes in the tumor microenvironment over time.

SourceMass General Brigham·JournalScience Translational Medicine·TypeExperimental study·DateOct 8, 2025

Alzheimer’s disease medication shows promise for improving social impairment in some youth with autism

A new study led by Mass General Brigham found that a glutamate-modulating drug called memantine may improve social functioning in youth with ASD who do not have intellectual disabilities. The treatment was associated with higher rates of improvement in social behaviors and was well-tolerated.

SourceMass General Brigham·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateOct 1, 2025

For people without diabetes, continuous glucose monitors may not accurately reflect blood sugar control

Researchers found that continuous glucose monitoring metrics correlated with hemoglobin A1c in patients with diabetes, but weakened or disappeared in those with prediabetes and normal glycemic control. CGMs are useful as behavioral tools for people without diabetes, but do not directly reflect longer-term blood sugar control.

SourceMass General Brigham·JournalDiabetes Technology & Therapeutics·TypeData/statistical analysis·DateOct 1, 2025

Study finds two forms of ketamine therapy can reduce symptom severity in patients with treatment-resistant depression

A new study led by Mass General Brigham investigators compared the effects of repeated intravenous (IV) ketamine and intranasal (IN) esketamine in patients with treatment-resistant depression, revealing both treatments reduced symptoms but IV ketamine showed greater improvements.

SourceMass General Brigham·JournalJournal of Clinical Psychiatry·TypeObservational study·DateSep 25, 2025

Genetic screening technique could enhance CAR-T therapies for multiple myeloma and other cancers

Researchers identified genetic modifications that can improve the efficacy of chimeric antigen receptor (CAR)-T cell treatment for multiple myeloma and other cancers. The study used CRISPR screening to pinpoint genes that influenced T cell function and survival in culture and in a preclinical model of multiple myeloma.

SourceMass General Brigham·JournalNature·TypeExperimental study·DateSep 24, 2025

The no surprises act has reduced patients’ out-of-pocket spending for medical care

A study by Mass General Brigham researchers found that the law significantly reduced out-of-pocket costs, but high burden medical spending remained unchanged. The findings suggest that additional policy efforts are needed to reduce healthcare-related financial burden, particularly among socioeconomically disadvantaged populations.

SourceMass General Brigham·JournalBMJ·TypeData/statistical analysis·DateAug 27, 2025

Researchers find link between history of traumatic brain injury and development of malignant brain tumor

A recent study by Mass General Brigham researchers found that adults with a history of moderate-to-severe traumatic brain injuries are at a higher risk of developing malignant brain tumors. The study evaluated data from over 75,000 people and discovered a significant association between TBI and increased tumor development.

SourceMass General Brigham·JournalJAMA Network Open·TypeData/statistical analysis·DateAug 25, 2025

Mediterranean diet may offset genetic risk of Alzheimer's

Researchers found that a Mediterranean-style diet helps reduce dementia risk and slow cognitive decline in people with high genetic risk for Alzheimer's disease. The diet has been shown to broadly influence key metabolic pathways, suggesting it could be an effective strategy for reducing the risk of cognitive decline.

SourceMass General Brigham·JournalNature Medicine·TypeObservational study·DateAug 25, 2025

Research Spotlight: Investigating the safety and efficacy of a hypoglossal nerve stimulator in young children with Down syndrome

Researchers found the treatment to be safe in all 29 children, with no serious adverse events. The device showed striking reductions in sleep apnea events, with over 95% of children achieving an OAHI reduction of more than 50%. This study provides hope for parents and offers implications for FDA approval and future trials.

SourceMass General Brigham·JournalInternational Journal of Pediatric Otorhinolaryngology·TypeObservational study·DateAug 5, 2025

Efforts underway to end race-based assessments of lung function

A multi-institutional team has proposed updates to national guidelines to remove race-based assessments from lung function testing. The authors highlight the need for a more equitable evaluation system, warning against overreliance on objective cutoff-based criteria. Several healthcare systems have already shifted to race-neutral refer...

SourceMass General Brigham·JournalNew England Journal of Medicine·DateJul 30, 2025

Clinical trial finds safe, effective treatment for children with severe post-Covid syndrome

Researchers at Mass General Brigham found larazotide effective in treating children with multisystem inflammatory syndrome in children (MIS-C), a rare but serious condition. The oral drug strengthened intestinal barriers to limit SARS-CoV-2 viral particle entry, resolving symptoms and improving recovery.

SourceMass General Brigham·JournalScience Translational Medicine·TypeRandomized controlled/clinical trial·DateJul 30, 2025

Research spotlight: Insights into palliative care for patients with cancer

A study of Medicare beneficiaries with poor-prognosis cancers found that outpatient palliative care visits doubled, mostly driven by advanced practice clinicians. However, a minority of decedents received any specialty palliative care, and access remained low for older adults, those with lower incomes, and those living in nonmetropolit...

SourceMass General Brigham·JournalJAMA Network Open·TypeObservational study·DateJul 25, 2025

Study compares common type 2 diabetes drugs, finding higher cardiovascular risk for one medication

A recent study published in JAMA Network Open found that glipizide, a commonly used type 2 diabetes medication, is associated with a 13% increase in cardiovascular risk compared to dipeptidyl peptidase-4 (DPP-4) inhibitors. The study analyzed data from nearly 50,000 patients and found that glipizide was linked to higher rates of heart ...

SourceMass General Brigham·JournalJAMA Network Open·TypeObservational study·DateJul 24, 2025

Study finds large language models (LLMs) use stigmatizing language about individuals with alcohol and substance use disorders

A new study by Mass General Brigham found that over 35% of responses from large language models contained stigmatizing language related to alcohol- and substance use-related conditions. However, targeted prompts can reduce this language substantially. The authors recommend using patient-centered language to build trust with patients.

SourceMass General Brigham·JournalJournal of Addiction Medicine·TypeRandomized controlled/clinical trial·DateJul 24, 2025

Study identifies potential therapeutic strategy to prevent complications from sickle cell disease

A new study by Mass General Brigham investigators identified an ancient immune pathway that is activated in patients with acute chest syndrome (ACS) and serves as a key driver of the disease. Blocking this pathway with clinically approved drugs alleviated disease severity in preclinical models.

SourceMass General Brigham·JournalScience Translational Medicine·TypeExperimental study·DateJul 17, 2025